AI Verdict
NAGE has stronger fundamentals based on our AI analysis.
NAGE vs NABL Fundamental Comparison
| Metric | NAGE | NABL |
|---|---|---|
| Revenue | $129.4M | $511.4M |
| Net Income | $17.4M | $-17.0M |
| Net Margin | 13.4% | -3.3% |
| ROE | 22.7% | -2.1% |
| ROA | 16.3% | -1.2% |
| Current Ratio | 4.86x | 1.19x |
| Debt/Equity | 0.13x | 0.49x |
| EPS | $0.20 | $-0.09 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAGE vs NABL: Frequently Asked Questions
Is NAGE or NABL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NAGE has stronger fundamentals. NAGE is rated BUY (78% confidence) while NABL is rated HOLD (70% confidence). This is not investment advice.
How does NAGE compare to NABL fundamentally?
Niagen Bioscience, Inc. has ROE of 22.7% vs N-able, Inc.'s -2.1%. Net margins are 13.4% vs -3.3% respectively.
Which stock pays higher dividends, NAGE or NABL?
NAGE has a dividend yield of N/A or no dividend while NABL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAGE or NABL for long term?
For long-term investing, consider that NAGE has BUY rating with 78% confidence, while NABL has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAGE vs NABL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAGE vs NABL, the AI consensus favors NAGE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.